<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00308737</url>
  </required_header>
  <id_info>
    <org_study_id>MKC-TI-030</org_study_id>
    <nct_id>NCT00308737</nct_id>
  </id_info>
  <brief_title>Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes</brief_title>
  <official_title>Pulmonary Outcomes Within a 2-Year Period in Subjects With Diabetes Mellitus Treated With Technosphere /Insulin or Usual Antidiabetic Treatment and in Subjects Without Abnormalities in Glucose Control.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mannkind Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mannkind Corporation</source>
  <brief_summary>
    <textblock>
      Pulmonary Safety in Diabetics with T/I
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual Care</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from Baseline to End of Study in FEV1 by MMRM</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1 Decrease of ≥ 15% From Baseline Value at Last Measurement for TI vs Usual Care</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>FEV1 decrease of ≥ 15% from Baseline value at last measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Last Measurement in FEV1 for TI vs Usual Care</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from Baseline to last measurement(Month 24) in FEV1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRM</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from Baseline to Month 24 in FVC by MMRM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRM</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from baseline to Month 24 in TLC by MMRM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRM</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from baseline to Month 24 in hemoglobin-corrected DLco by MMRM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced Vital Capacity (FVC) Decrease of ≥ 15% From Baseline Value at Last Measurement</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>FVC Decrease of ≥15% from Baseline Value at Last Measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Lung Capacity (TLC) Decrease of ≥ 15% From Baseline Value at Last Measurement</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>TLC Decrease of ≥ 15% from Baseline Value at Last Measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of ≥ 15% From Baseline Value at Last Measurement</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Hemoglobin-corrected DLco decrease of ≥ 15% from baseline value at last measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of &gt;3 ml/Min/mmHg From Baseline Value at Last Measurement</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Hemoglobin-corrected DLco decrease of &gt;3 ml/min/mmHg from baseline value at last measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual Care</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from baseline in HbA1c at last measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Weight From Baseline at Month 24</measure>
    <time_frame>Baseline to Month 24</time_frame>
    <description>Change from baseline in weight at Month 24</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">2053</enrollment>
  <condition>Diabetes, Type 1</condition>
  <condition>Diabetes, Type 2</condition>
  <arm_group>
    <arm_group_label>TI Inhalation Powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Technosphere® Insulin Inhalation Powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Usual care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-diabetes</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects without abnormalities in glucose control (Note: Hypoglycemia and HbA1c were not reported for this group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Technosphere® Insulin Inhalation Powder</intervention_name>
    <description>Inhalation, 15U/30U</description>
    <arm_group_label>TI Inhalation Powder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Subjects will receive antidiabetes treatment at the discretion of their physicians</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For All Subjects:

               -  Nonsmoking

               -  Body mass index &lt;42 kg/m2

               -  FEV1 greater than or equal to 70% of predicted , DLco and TLC greater than or
                  equal to 80% of predicted at screening,

               -  No abnormalities in screening pulmonary radiology

          -  For Subjects with diabetes mellitus:

               -  Type 1 or type 2 diabetes for at least 2 years

               -  HbA1c greater than or equal to 6.6 % and less than or equal to 12.0 %

          -  For Subjects without abnormalities in glucose control:

               -  No history of diabetes

               -  Normal results from a formal glucose tolerance test

        Exclusion Criteria:

          -  History of chronic obstructive pulmonary disease, asthma, or other significant
             pulmonary disease

          -  Significant renal, hepatic, or cardiac disease

          -  Women who are pregnant, lactating, or planning on becoming pregnant

          -  Subjects who have participated in studies of other investigational drugs within the
             previous 3 months

          -  Evidence of severe complications of diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Southwest Health Ltd Research Division</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Clinical Research</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Premiere Pharmaceutical Research LLC</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85282</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Canyon Clinical Research</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Research Associates</name>
      <address>
        <city>Tuscon</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice</name>
      <address>
        <city>Burlingame</city>
        <state>California</state>
        <zip>94010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Agnes Medical Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Research</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>(Private Practice)</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92840</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes/Lipid Management Center</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92648</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Interlink Research Institute</name>
      <address>
        <city>Los Alamitos</city>
        <state>California</state>
        <zip>90720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes Care Center</name>
      <address>
        <city>Salinas</city>
        <state>California</state>
        <zip>93901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Diego Sports Medicine and Family Health Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dorothy L &amp; James E Frank Diabetes Research Institute</name>
      <address>
        <city>San Mateo</city>
        <state>California</state>
        <zip>94401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sansum Medical Research Institute</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Encompass Clinical Research</name>
      <address>
        <city>Spring Valley</city>
        <state>California</state>
        <zip>91978</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Denver VA Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance Medical Group of Greater Waterbury</name>
      <address>
        <city>Middlebury</city>
        <state>Connecticut</state>
        <zip>06762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Britain General Hosptal c?o Betsy Keller</name>
      <address>
        <city>New Britain</city>
        <state>Connecticut</state>
        <zip>06050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chase Medical Research, LLC</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <zip>06708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Perimeter Institute for Clinical Research (PICR)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Executive Health and Research Associates Inc</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rockdale Medical Research Associates</name>
      <address>
        <city>Conyers</city>
        <state>Georgia</state>
        <zip>30094</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Private Practice</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30035-4000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlanta Pharmaceutical Research Center</name>
      <address>
        <city>Dunwoody</city>
        <state>Georgia</state>
        <zip>30338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Atlanta Endocrinology &amp; Diabetes PC</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <zip>30045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeastern Endocrine &amp; Diabetes</name>
      <address>
        <city>Roswell</city>
        <state>Georgia</state>
        <zip>30076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fox Valley Clinical Research Center LLC</name>
      <address>
        <city>Aurora</city>
        <state>Illinois</state>
        <zip>60504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedar-Crosse Research Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deerbrook Medical Associates</name>
      <address>
        <city>Vernon Hills</city>
        <state>Illinois</state>
        <zip>60061</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research of Louisiana</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic and Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Trends Research LLC</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21208-6391</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franklin Square Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MODEL Clinical Research</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Coast Clinical Research Inc</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research</name>
      <address>
        <city>Waltham</city>
        <state>Massachusetts</state>
        <zip>02453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Institute of Medicine</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PPS Clinical Research / Southwest Medical Center</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Healthcare Research</name>
      <address>
        <city>Florissant</city>
        <state>Missouri</state>
        <zip>63031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedEx Healthcare Research Inc</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Research</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Billings Clinic Research Division</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Your Doctors Care</name>
      <address>
        <city>Hillsborough</city>
        <state>New Jersey</state>
        <zip>08844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopewell Valley Family Medicine PA</name>
      <address>
        <city>Trenton</city>
        <state>New Jersey</state>
        <zip>08618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Umdnj-Som</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08084</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Clinical Research &amp; Osteoporosis Center</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lovelace Scientific Resources (Albuquerque)</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Endocrinology Associates</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physicians Associates of Park Place</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes Care &amp; Information Center of New York</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11365</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastside Comprehensive Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M.E.R.I.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physicians Clinical Research Service (PCRS) (SMO)</name>
      <address>
        <city>White Plains</city>
        <state>New York</state>
        <zip>10604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metrolina Medical Research</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrine Research - Physician's East PA</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rapid Medical Research Inc</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Your Diabetes Endocrine Nutrition Group</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Hope Research of Oregon</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buckingham Family Medicine</name>
      <address>
        <city>Doyleston</city>
        <state>Pennsylvania</state>
        <zip>18912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bucks County Clinical Research</name>
      <address>
        <city>Morrisville</city>
        <state>Pennsylvania</state>
        <zip>19067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upstate Pharmaceutical Research</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Familicare Clinical Research</name>
      <address>
        <city>Colleyville</city>
        <state>Texas</state>
        <zip>76034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas Diabetes &amp; Endocrine Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Medical Research Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Texas Medical Research</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes &amp; Glandular Disease Research Assoc PA</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott &amp; White Hospital and Clinic</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McLennan County Medical Education and Research Foundation</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magna Center for Family Medicine</name>
      <address>
        <city>Magna</city>
        <state>Utah</state>
        <zip>84044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Davis Family Practice</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research Salt Lake City</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeastern PA Med Inst LLC (SMO)</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Granger Medical Clinic</name>
      <address>
        <city>West Valley City</city>
        <state>Utah</state>
        <zip>84120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hampton Roads Center for Clinical Research Inc</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rainier Clinical Research Center Inc</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Department Wenatchee Valley Medical Center</name>
      <address>
        <city>Wenatchee</city>
        <state>Washington</state>
        <zip>98801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Finchlea Medical Group</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6T 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Courtice Health Centre</name>
      <address>
        <city>Courtice, Ontario</city>
        <state>Ontario</state>
        <zip>L1E 3C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkwood Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6C 5J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Quest Clinical Trials</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>L6B 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sarnia Institute of Clinical Research</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <zip>N7T 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The London Road Diagnostic Clinic and Medical Centre</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <zip>N7T 4X3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lifestyle Metabolism Center</name>
      <address>
        <city>Thornhill</city>
        <state>Ontario</state>
        <zip>L4J 8L7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4K 1N5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lifestyle Metabolism Center (600-118 Eglinton Ave W)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4R 2G4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manna Research</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M9W 4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetologicka ambulance</name>
      <address>
        <city>Litomerice</city>
        <state>CZE</state>
        <zip>41201</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surgery of Diabetology</name>
      <address>
        <city>Melnik</city>
        <state>CZE</state>
        <zip>276 01</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internal Clinic</name>
      <address>
        <city>Ostrava - Poruba</city>
        <state>CZE</state>
        <zip>708 52</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetologicka a interni ambulance</name>
      <address>
        <city>Ostrava 1</city>
        <state>CZE</state>
        <zip>70200</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetologicka a interni ambulance</name>
      <address>
        <city>Ostrava-Kuncice</city>
        <state>CZE</state>
        <zip>70702</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Surgery of Diabetology Petrovice</name>
      <address>
        <city>Prague 15</city>
        <state>CZE</state>
        <zip>109 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Motol Interni Klinika</name>
      <address>
        <city>Praha 6</city>
        <state>CZE</state>
        <zip>150 06</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Endocrinologii Diabetologii I</name>
      <address>
        <city>Bialystock</city>
        <state>POL</state>
        <zip>15-276</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Chorob Wewnetrznych</name>
      <address>
        <city>Bialystock</city>
        <state>POL</state>
        <zip>15-950</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dzial Badan Klinicznych Malopoiskie</name>
      <address>
        <city>Krakow</city>
        <state>POL</state>
        <zip>30 510</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endokrynologiczno Metaboliczne DIAB_ENDO_MET</name>
      <address>
        <city>Krakow</city>
        <state>POL</state>
        <zip>31-261</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>III Oddzial Chorob Wewnetrznych Szpital</name>
      <address>
        <city>Krakow</city>
        <state>POL</state>
        <zip>31121</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Internistyczny Specjalistyczna</name>
      <address>
        <city>Lask</city>
        <state>POL</state>
        <zip>98-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Wewnetrzny B</name>
      <address>
        <city>Lodz</city>
        <state>POL</state>
        <zip>092-003</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klliniczny nr 1 im Norberta Barlickiego Uniwersytetu Medycznego w Lodzi</name>
      <address>
        <city>Lodz</city>
        <state>POL</state>
        <zip>90 153</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Diabetologiczny Centrum</name>
      <address>
        <city>Lodz</city>
        <state>POL</state>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spzital Kolejowy imm Wlodzimierza Roeflera</name>
      <address>
        <city>Pruszkow</city>
        <state>POL</state>
        <zip>05-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Gastroentereologii i</name>
      <address>
        <city>Warsaw</city>
        <state>POL</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Chorob Wewnetznych i Diabetologii</name>
      <address>
        <city>Warsaw</city>
        <state>POL</state>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ZPZOZ w Otwocku Szpital Miejski</name>
      <address>
        <city>Warsaw</city>
        <state>POL</state>
        <zip>05-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Medycyny Rodzinnej i Chorob</name>
      <address>
        <city>Warszawa</city>
        <state>POL</state>
        <zip>00-416</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kemerovo State Medical Academy of Ministry of Health</name>
      <address>
        <city>Kemerovo</city>
        <state>RUS</state>
        <zip>650061</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHI Kemerovo Regional Clinical Hospital</name>
      <address>
        <city>Kemerovo</city>
        <state>RUS</state>
        <zip>650061</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>105229</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russian State Medical University City Hospital # 4</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>113093</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NI Endrocrinological Research Centre of RAMS In patient replacing technologies department</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>115478</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russian Academy of Medical Sciences National Research Ctr for Endocrinology Institute of Diabetes</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russian State Medical University Central Clinical Hospital Russian Science Academy</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>117593</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RAAMS Endocrinology and Diabetology Department</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>125315</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SIH of Moscow City Clinical Hopsital #81 Endocrinology and Diabetology</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>127644</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Clinical Hospital #13</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moscow State Medical-Stomatological University City Clinical Hospital # 23</name>
      <address>
        <city>Moscow</city>
        <state>RUS</state>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ryazan State Medical University na academician IP Pavlov</name>
      <address>
        <city>Ryazan</city>
        <state>RUS</state>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital</name>
      <address>
        <city>Smolensk</city>
        <state>RUS</state>
        <zip>214018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krestovsky Island Medical Institute</name>
      <address>
        <city>St Petersburg</city>
        <state>RUS</state>
        <zip>107110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Petersburg NHI City Polytclinic #77 City Diabetological Center #4</name>
      <address>
        <city>St Petersburg</city>
        <state>RUS</state>
        <zip>193012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Medical Sanitary Unit #122</name>
      <address>
        <city>St Petersburg</city>
        <state>RUS</state>
        <zip>194291</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Petersburg Medical Academy St Elizabeth Hospital</name>
      <address>
        <city>St Petersburg</city>
        <state>RUS</state>
        <zip>195257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pavlov State Medical Univ of St Petersburg</name>
      <address>
        <city>St Petersburg</city>
        <state>RUS</state>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Petersburg NHI Municipal Multi-Speciality Hospital # 2</name>
      <address>
        <city>St. Petersburg</city>
        <state>RUS</state>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Pharm Dept of Yaroslavl Clin Hospital</name>
      <address>
        <city>Yaroslavl</city>
        <state>RUS</state>
        <zip>150003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHI Clinical Hospital for Emergency Care na NV Soloviev</name>
      <address>
        <city>Yaroslavl</city>
        <state>RUS</state>
        <zip>150003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHI Yaroslavl Regional Clinical Hospital</name>
      <address>
        <city>Yaroslavl</city>
        <state>RUS</state>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yaroslavl Regional Clinical Hospital</name>
      <address>
        <city>Yaroslavl</city>
        <state>RUS</state>
        <zip>150062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Institution Pulmonology Research Institute of Federal Agency of HC&amp;SD</name>
      <address>
        <city>Moscow</city>
        <zip>105077</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacio Sarda Farriol</name>
      <address>
        <city>Barcelona</city>
        <state>ESP</state>
        <zip>08017</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacion Jimenez Diaz Servicio Endocrinologia y Nutricion</name>
      <address>
        <city>Madrid</city>
        <state>ESP</state>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre Consultas Extremas - Endocrinologia</name>
      <address>
        <city>Madrid</city>
        <state>ESP</state>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de la Paz</name>
      <address>
        <city>Madrid</city>
        <state>ESP</state>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sevilla</city>
        <state>ESP</state>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Univ Virgen del Rocío Scio Endocrinología Centro de Diagnosticos Pl Baja</name>
      <address>
        <city>Sevilla</city>
        <state>ESP</state>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic I Provincial</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bukovinian State Medical University Dept of Clinical Immun</name>
      <address>
        <city>Chernivtcy</city>
        <state>UKR</state>
        <zip>58022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dniepropetrovsh State Medical Academy</name>
      <address>
        <city>Dniepropetrovsk</city>
        <state>UKR</state>
        <zip>49023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donetsk State Medical University</name>
      <address>
        <city>Donetsk</city>
        <state>UKR</state>
        <zip>83003</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donetsk State Medical University</name>
      <address>
        <city>Donetsk</city>
        <state>UKR</state>
        <zip>83009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Railway Clinical Hospital on Donetsk Station</name>
      <address>
        <city>Donetsk</city>
        <state>UKR</state>
        <zip>83114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V Danilevsky Inst of Endocrinology Pathology</name>
      <address>
        <city>Kharkiv</city>
        <state>UKR</state>
        <zip>61070</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University at Kiev Center of Endocrinology and Metab</name>
      <address>
        <city>Kiev</city>
        <state>UKR</state>
        <zip>01004</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chair Family Med of National Med University</name>
      <address>
        <city>Kiev</city>
        <state>UKR</state>
        <zip>04050</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ukr Scientifically Practical Centre of Endocrine Surgery</name>
      <address>
        <city>Kiev</city>
        <state>UKR</state>
        <zip>2175</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lugansk State Medical University Chair of Hosp Therapy #2</name>
      <address>
        <city>Lugansk</city>
        <state>UKR</state>
        <zip>91045</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lugansk State Medical University Chair of Therapy #1</name>
      <address>
        <city>Lugansk</city>
        <state>UKR</state>
        <zip>91045</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chair of Endocrin &amp; Clinical Pharmacology of Lvov State Medical University</name>
      <address>
        <city>Lvov</city>
        <state>UKR</state>
        <zip>79010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odessa State Medical University Dept of Gen Practice and Med Rehab</name>
      <address>
        <city>Odessa</city>
        <state>UKR</state>
        <zip>65009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odessa Reg. Clinical Hosp Outpatient Department</name>
      <address>
        <city>Odessa</city>
        <state>UKR</state>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odessa State Med Dept of Family Med and Gen Practice</name>
      <address>
        <city>Odessa</city>
        <state>UKR</state>
        <zip>65039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crimean State Medical University Dept of Therapy #1</name>
      <address>
        <city>Simferopol</city>
        <state>UKR</state>
        <zip>95017</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vinnitsa State Medical University</name>
      <address>
        <city>Vinnitsa</city>
        <state>UKR</state>
        <zip>21020</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Outpatient Clinic of Family Physician &quot;Rusanovka&quot;</name>
      <address>
        <city>Kiev</city>
        <zip>02147</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Public Institution City Policlinic #20 Odessa</name>
      <address>
        <city>Odessa</city>
        <zip>65114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnsley Hospital</name>
      <address>
        <city>Barnsley</city>
        <state>GBR</state>
        <zip>S75 2EP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingthorne Group Practice</name>
      <address>
        <city>Doncaster</city>
        <state>GBR</state>
        <zip>DN3 2LX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manny Cussins Centre</name>
      <address>
        <city>Leeds</city>
        <state>GBR</state>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal liverpool University Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>GBR</state>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Centre The Royal London Hospital</name>
      <address>
        <city>London</city>
        <state>GBR</state>
        <zip>E1 2AT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medinova Research Mount Vernon Hospital</name>
      <address>
        <city>Middlesex</city>
        <state>GBR</state>
        <zip>HA6 2RN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edith Cavel Hospital Diabetes Centre</name>
      <address>
        <city>Petersborough</city>
        <state>GBR</state>
        <zip>PE3 9GZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <state>GBR</state>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Woolpit Medical Practice</name>
      <address>
        <city>Suffolk</city>
        <state>GBR</state>
        <zip>IP30 9QU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Suffolk Hospital</name>
      <address>
        <city>Suffolk</city>
        <state>GBR</state>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Heartland Hospital</name>
      <address>
        <city>West Midlands</city>
        <state>GBR</state>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bradford Hospital Dept of Diabetes &amp; Endocrinology</name>
      <address>
        <city>West Yorkshire</city>
        <state>GBR</state>
        <zip>BD9 6RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2006</study_first_submitted>
  <study_first_submitted_qc>March 28, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2006</study_first_posted>
  <results_first_submitted>July 22, 2014</results_first_submitted>
  <results_first_submitted_qc>October 9, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 16, 2014</results_first_posted>
  <disposition_first_submitted>June 9, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>October 1, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">October 5, 2009</disposition_first_posted>
  <last_update_submitted>October 9, 2014</last_update_submitted>
  <last_update_submitted_qc>October 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>First subject enrolled July 25, 2005 Multi-national trial conducted in Canada, Czech Republic, Poland, Russia, Spain, Ukraine, UK, and US</recruitment_details>
      <pre_assignment_details>Subjects were required to meet all inclusion/exclusion criteria 3741 screened/2053 eligible of which all were randomized, including 164 non-diabetics - 1688 screen failures
17 diabetics randomized but not dosed
1 non-diabetic elected not to participate</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Technosphere® Insulin</title>
          <description>Technosphere Insulin with or without basal insulin, or oral anti-diabetic medications, or any combination of the previous.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Usual care may consist of oral anti-diabetic medications, basal insulin, subcutaneous prandial insulin, or any combination of the previous.</description>
        </group>
        <group group_id="P3">
          <title>Non-diabetes</title>
          <description>Subjects without abnormalities in glucose control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="938"/>
                <participants group_id="P2" count="951"/>
                <participants group_id="P3" count="164"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="475"/>
                <participants group_id="P2" count="662"/>
                <participants group_id="P3" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="463"/>
                <participants group_id="P2" count="289"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="80"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="218"/>
                <participants group_id="P2" count="166"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Various</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Safety population, excluding subjects who were not dosed with study medication (17 diabetics randomized but not dosed, 1 non-diabetic elected not to participate)</population>
      <group_list>
        <group group_id="B1">
          <title>Technosphere® Insulin</title>
          <description>Technosphere Insulin</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Usual care</description>
        </group>
        <group group_id="B3">
          <title>Non-diabetes</title>
          <description>Subjects without abnormalities in glucose control</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="923"/>
            <count group_id="B2" value="949"/>
            <count group_id="B3" value="163"/>
            <count group_id="B4" value="2035"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.8" spread="11.55"/>
                    <measurement group_id="B2" value="50.4" spread="11.62"/>
                    <measurement group_id="B3" value="38.2" spread="12.59"/>
                    <measurement group_id="B4" value="49.6" spread="12.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="366"/>
                    <measurement group_id="B2" value="371"/>
                    <measurement group_id="B3" value="92"/>
                    <measurement group_id="B4" value="829"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="557"/>
                    <measurement group_id="B2" value="578"/>
                    <measurement group_id="B3" value="71"/>
                    <measurement group_id="B4" value="1206"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <description>Body mass index</description>
          <units>kilograms per meter squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.87" spread="5.366"/>
                    <measurement group_id="B2" value="29.76" spread="5.035"/>
                    <measurement group_id="B3" value="25.27" spread="4.494"/>
                    <measurement group_id="B4" value="29.5" spread="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>HbA1c</title>
          <description>Glycated hemoglobin</description>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.7" spread="1.39"/>
                    <measurement group_id="B2" value="8.7" spread="1.38"/>
                    <measurement group_id="B3" value="0" spread="0"/>
                    <measurement group_id="B4" value="8.4" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <description>Weight in kilograms</description>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87.69" spread="18.628"/>
                    <measurement group_id="B2" value="87.53" spread="17.638"/>
                    <measurement group_id="B3" value="74.35" spread="16.204"/>
                    <measurement group_id="B4" value="86.6" spread="18.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual Care</title>
        <description>Change from Baseline to End of Study in FEV1 by MMRM</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>Intention to Treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual Care</title>
          <description>Change from Baseline to End of Study in FEV1 by MMRM</description>
          <population>Intention to Treat (ITT)</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="824"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.208"/>
                    <measurement group_id="O2" value="-0.12" spread="0.211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed model repeated measures with fixed effects diabetes type, visit, pooled site and treatment and baseline FEV1 as a covariate</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Comparison of TI + Usual Care to Usual Care only</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.037</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.014</ci_lower_limit>
            <ci_upper_limit>0.060</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Last Measurement in FEV1 for TI vs Usual Care</title>
        <description>Change from Baseline to last measurement(Month 24) in FEV1</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>Intention to Treat (ITT) with Last Observation Carried Forward (LOCF)</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Last Measurement in FEV1 for TI vs Usual Care</title>
          <description>Change from Baseline to last measurement(Month 24) in FEV1</description>
          <population>Intention to Treat (ITT) with Last Observation Carried Forward (LOCF)</population>
          <units>liters</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="824"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.128" lower_limit="-0.144" upper_limit="-0.113"/>
                    <measurement group_id="O2" value="-0.092" lower_limit="-0.107" upper_limit="-0.077"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ANCOVA model with treatment site, diabetes type, and baseline FEV1</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis tested was that the FEV1 change from Baseline for the TI group is no greater than 50 mL/year above the change in the usual care treatment group. Assuming SD of 100 mL/y, 80% power, and 5% (1-tailed) significance level, it was determined that 50 subjects were required for each of the diabetes treatment groups. Final sample size was selected for the incidence of a &gt;= 15% decrease in FEV1 end point.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.037</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.016</ci_lower_limit>
            <ci_upper_limit>0.057</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRM</title>
        <description>Change from Baseline to Month 24 in FVC by MMRM</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>Intention to Treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRM</title>
          <description>Change from Baseline to Month 24 in FVC by MMRM</description>
          <population>Intention to Treat (ITT)</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="824"/>
                <count group_id="O3" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.242"/>
                    <measurement group_id="O2" value="-0.11" spread="0.262"/>
                    <measurement group_id="O3" value="-0.09" spread="0.210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed model repeated measures with fixed effects diabetes type, visit, pooled site and treatment and baseline FVC as a covariate</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.034</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.008</ci_lower_limit>
            <ci_upper_limit>0.061</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRM</title>
        <description>Change from baseline to Month 24 in TLC by MMRM</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>participants in ITT population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRM</title>
          <description>Change from baseline to Month 24 in TLC by MMRM</description>
          <population>participants in ITT population with available data</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="717"/>
                <count group_id="O2" value="817"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.321"/>
                    <measurement group_id="O2" value="-0.07" spread="0.322"/>
                    <measurement group_id="O3" value="-0.02" spread="0.297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed model repeated measures with fixed effects diabetes type, visit, pooled site, and treatment and baseline TLC as a covariate</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.005</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.042</ci_lower_limit>
            <ci_upper_limit>0.031</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRM</title>
        <description>Change from baseline to Month 24 in hemoglobin-corrected DLco by MMRM</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>participants in ITT population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRM</title>
          <description>Change from baseline to Month 24 in hemoglobin-corrected DLco by MMRM</description>
          <population>participants in ITT population with available data</population>
          <units>mL/min/mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="723"/>
                <count group_id="O2" value="818"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.60" spread="2.830"/>
                    <measurement group_id="O2" value="-1.36" spread="2.862"/>
                    <measurement group_id="O3" value="-1.33" spread="3.203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed model repeated measures with fixed effects diabetes type, visit, pooled site, and treatment and baseline TLC as a covariate</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.269</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.037</ci_lower_limit>
            <ci_upper_limit>0.574</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Forced Vital Capacity (FVC) Decrease of ≥ 15% From Baseline Value at Last Measurement</title>
        <description>FVC Decrease of ≥15% from Baseline Value at Last Measurement</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>participants in ITT population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Forced Vital Capacity (FVC) Decrease of ≥ 15% From Baseline Value at Last Measurement</title>
          <description>FVC Decrease of ≥15% from Baseline Value at Last Measurement</description>
          <population>participants in ITT population with available data</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="824"/>
                <count group_id="O3" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Logistic regression excluding non-diabetics</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.6475</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.3432</ci_lower_limit>
            <ci_upper_limit>1.2219</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Lung Capacity (TLC) Decrease of ≥ 15% From Baseline Value at Last Measurement</title>
        <description>TLC Decrease of ≥ 15% from Baseline Value at Last Measurement</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>participants in ITT population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Total Lung Capacity (TLC) Decrease of ≥ 15% From Baseline Value at Last Measurement</title>
          <description>TLC Decrease of ≥ 15% from Baseline Value at Last Measurement</description>
          <population>participants in ITT population with available data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="717"/>
                <count group_id="O2" value="817"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Logistic regression excluding non-diabetics</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.7504</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.2510</ci_lower_limit>
            <ci_upper_limit>2.2431</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of ≥ 15% From Baseline Value at Last Measurement</title>
        <description>Hemoglobin-corrected DLco decrease of ≥ 15% from baseline value at last measurement</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>participants in ITT population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of ≥ 15% From Baseline Value at Last Measurement</title>
          <description>Hemoglobin-corrected DLco decrease of ≥ 15% from baseline value at last measurement</description>
          <population>participants in ITT population with available data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="723"/>
                <count group_id="O2" value="818"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105"/>
                    <measurement group_id="O2" value="108"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Logistic regression excluding non-diabetics</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.8953</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.6703</ci_lower_limit>
            <ci_upper_limit>1.1958</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of &gt;3 ml/Min/mmHg From Baseline Value at Last Measurement</title>
        <description>Hemoglobin-corrected DLco decrease of &gt;3 ml/min/mmHg from baseline value at last measurement</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>participants in ITT population with available data</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of &gt;3 ml/Min/mmHg From Baseline Value at Last Measurement</title>
          <description>Hemoglobin-corrected DLco decrease of &gt;3 ml/min/mmHg from baseline value at last measurement</description>
          <population>participants in ITT population with available data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="723"/>
                <count group_id="O2" value="818"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181"/>
                    <measurement group_id="O2" value="181"/>
                    <measurement group_id="O3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Logistic regression excluding non-diabetics</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Odds Ratio, log</param_type>
            <param_value>0.8509</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.6722</ci_lower_limit>
            <ci_upper_limit>1.0770</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual Care</title>
        <description>Change from baseline in HbA1c at last measurement</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>Intention to treat (ITT) with last observation carried forward (LOCF)</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual Care</title>
          <description>Change from baseline in HbA1c at last measurement</description>
          <population>Intention to treat (ITT) with last observation carried forward (LOCF)</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="725"/>
                <count group_id="O2" value="818"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.42" spread="1.410"/>
                    <measurement group_id="O2" value="-0.49" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Weight From Baseline at Month 24</title>
        <description>Change from baseline in weight at Month 24</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>Safety population at Month 24</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
          <group group_id="O3">
            <title>Non-diabetes</title>
            <description>Subjects without abnormalities in glucose control</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Weight From Baseline at Month 24</title>
          <description>Change from baseline in weight at Month 24</description>
          <population>Safety population at Month 24</population>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="185"/>
                <count group_id="O2" value="664"/>
                <count group_id="O3" value="126"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="6.653"/>
                    <measurement group_id="O2" value="1.64" spread="5.066"/>
                    <measurement group_id="O3" value="1.19" spread="4.457"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Two sample t-test</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.112</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FEV1 Decrease of ≥ 15% From Baseline Value at Last Measurement for TI vs Usual Care</title>
        <description>FEV1 decrease of ≥ 15% from Baseline value at last measurement</description>
        <time_frame>Baseline to Month 24</time_frame>
        <population>Intention to Treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Technosphere® Insulin</title>
            <description>Technosphere Insulin</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>FEV1 Decrease of ≥ 15% From Baseline Value at Last Measurement for TI vs Usual Care</title>
          <description>FEV1 decrease of ≥ 15% from Baseline value at last measurement</description>
          <population>Intention to Treat (ITT)</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="730"/>
                <count group_id="O2" value="824"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Logistic regression excluding non-diabetics</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis tested was that the difference in incidence of a decrease of ≥ 15% in FEV1 between the treatment groups not be greater than 5% for TI when compared with the usual care treatment group. Assuming an incidence rate of 15% for FEV1 and a noninferiority criterion of a 5% difference in incidence between the treatment groups, approximately 625 subjects per group were required for 80% power and an alpha of 5% (1 tailed).</non_inferiority_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>-2.4767</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.5578</ci_lower_limit>
            <ci_upper_limit>-0.3956</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Technosphere® Insulin</title>
          <description>Technosphere Insulin</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Usual care (taking insulin)</description>
        </group>
        <group group_id="E3">
          <title>Non-diabetes</title>
          <description>Subjects without abnormalities in glucose control</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 7.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="92" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="91" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Thrombocythaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pernicious anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Coronary artery atherosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Retinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Benign colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pancreatic necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hepatotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cellulitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Injection site cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Postoperative infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Staphylococcal scalded skin syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Chronic tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic seizure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Ketosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Diabetic complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Localised osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Spondylosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Benign salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Ovarian epithelial cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Radiculitis lumbosacral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Adenomyosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Atherosclerosis obliterans</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 7.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="559" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="472" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="47" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="119" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="143" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="163"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="67" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="69" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="365" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="370" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="257" subjects_at_risk="923"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="949"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="163"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chief Medical Officer</name_or_title>
      <organization>MannKind Corporation</organization>
      <phone>201-983-5000</phone>
      <email>aboss@mannkindcorp.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

